Skip to main content

Company

Express Scripts

74 published works

  1. Your ERISA Watch

    Third Circuit Holds That Plan Participants Lack Standing to Challenge MetLife’s Retention of Prescription Drug Rebates

    By KKLP Marketing

    Knudsen v. MetLife Grp., Inc., No. 23-2420, __ F.4th __, 2024 WL 4282967 (3d Cir. Sept. 25, 2024) (Before Circuit Judges Restrepo, Freeman, and McKee) Under the “case or controversy”…

  2. Global Policy Watch

    Court Denies Class Certification in Antitrust Case Based on Expert’s Reliance on Unsupported Assumptions in Damages Model

    By Brandon Gould

    The Northern District of Illinois recently denied certification to several proposed classes of purchasers of a seizure drug called Acthar in City of Rockford v. Mallinckrodt ARD, Inc., No. 3:17-cv-50107, 2024…

  3. Inside Class Actions

    Court Denies Class Certification in Antitrust Case Based on Expert’s Reliance on Unsupported Assumptions in Damages Model

    By Brandon Gould

    The Northern District of Illinois recently denied certification to several proposed classes of purchasers of a seizure drug called Acthar in City of Rockford v. Mallinckrodt ARD, Inc., No. 3:17-cv-50107,…

  4. Napoli Shkolnik Blog

    Lawsuit Filed Insulin Pricing Scheme Complaint on Behalf of Cattaraugus County, NY Against 19 Major Players in Pharma Industry

    By Napoli Shkolnik PLLC

    Complaint Claims Opaque, Conspiratorial Kickback Scheme Exponentially Increased Defendants’ Profits at the Expense of Plaintiff, its Plan Members and Other Payers Napoli Shkolnik has filed a lawsuit on behalf of…

  5. Hunton Employment & Labor Perspectives

    New Jersey Federal Court Grants Reconsideration in Favor of Employer on FLSA Exemption for Highly Compensated Employee

    By Christopher M. Pardo, Katherine P. Sandberg

    In a recent decision in Perez v. Express Scripts, Inc., the U.S. District Court for the District of New Jersey determined that plaintiff and a conditionally certified class of 200…

  6. Pharmacy & Healthcare Legal Blog

    A pharmacy sues ESI based on specialty drug reimbursement

    By Natalia Mazina

    For a long time, reimbursement for specialty drugs have been a subject of heated debates and controversies.  A reason for this could be a lack of clear definition of  what…

  7. Hall Benefits Law Blog

    FTC Opens Inquiry into Nation’s Largest PBMs

    By Anne Hall

    The Federal Trade Commission (FTC) has announced an investigation into the nation’s six largest pharmacy benefit managers (PBMs). The targeted PBMs include CVS Caremark, Express Scripts, OptumRx, Humana, Prime Therapeutics,…

  8. Big Molecule Watch

    Express Scripts Adds Biosimilar SEMGLEE to Preferred Formulary

    By Gabriella Montes

    In October, Express Scripts announced that it would add Viatris’ SEMGLEE (insulin glargine-yfgn) injection as a preferred therapy on its formulary beginning in January 2022. Back in July, the FDA…

  9. SALT Shaker

    Successfully defending sales factor sourcing adjustments

    By Chris Lee, Jeremy Gove

    In this episode of the SALT Shaker Podcast, host and Associate Chris Lee is joined by Associate Jeremy Gove to discuss a decision by the Indiana Tax Court involving Express Scripts. Transactions are…

  10. Delaware Courts

    Sorting Through the Kettle of Fish: Delaware Supreme Court Enforces Contractual Provisions Limiting Liability to “Deliberate Fraud”

    By Alexis Wendl, Gil Kahn

    When determining whether to uphold an indemnification provision that carved out an exception for only deliberate fraud, the Delaware Supreme Court recently explained in Express Scripts, Inc. v. Bracket Holding…